145773-21-3 Usage
Uses
Used in Pharmaceutical Industry:
(1S,5R,6R,7R)-6-<(3R)-3-hydroxy-5-phenyl-1-pentyl>-7(R)-hydroxy-2-oxabicyclo<3.3.0>octan-3-one is used as a potential pharmaceutical agent due to its unique molecular structure and potential biological activity. Its specific functional groups and stereochemistry make it a promising candidate for the development of new drugs and therapies.
Used in Chemical Research:
(1S,5R,6R,7R)-6-<(3R)-3-hydroxy-5-phenyl-1-pentyl>-7(R)-hydroxy-2-oxabicyclo<3.3.0>octan-3-one is used as a research tool for studying chemical reactions and functional groups. Its intricate structure and stereochemistry provide valuable insights into the behavior of complex organic compounds and their interactions with other molecules.
Used in Medicinal Chemistry:
(1S,5R,6R,7R)-6-<(3R)-3-hydroxy-5-phenyl-1-pentyl>-7(R)-hydroxy-2-oxabicyclo<3.3.0>octan-3-one is used in medicinal chemistry for the development of new drugs and therapies. Its unique molecular structure and potential biological activity make it a valuable compound for exploring novel approaches to treating various diseases and medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 145773-21-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,7,7 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 145773-21:
(8*1)+(7*4)+(6*5)+(5*7)+(4*7)+(3*3)+(2*2)+(1*1)=143
143 % 10 = 3
So 145773-21-3 is a valid CAS Registry Number.
145773-21-3Relevant academic research and scientific papers
PREPARATION OF PROSTAGLANDIN DERIVATIVES
-
Page/Page column 20, (2012/02/05)
A process for preparing the prostaglandin derivatives is provided, wherein the benzoyl and p-nitrobenzoyl groups are used as the hydroxyl protective groups. A pharmaceutical composition comprising the prostaglandin derivatives is also provided.
Phenyl-Substituted Prostaglandins: Potent and Selective Antiglaucoma Agents
Resul, Bahram,Stjernschantz, Johan,No, Kiyo,Liljebris, Charlotta,Selen, Goeran,et al.
, p. 243 - 248 (2007/10/02)
A series of phenyl-substituted analoques of prostaglandin F2α (PGF2α) were prepared and evaluated for ocular hypotensive effect and side effects in different animal models.In addition, the activity of the analogues on FP receptors was studied in vitro.The results were compared with those of PGF2α and its isopropyl ester.The phenyl-substituted PGF2α analogues exhibited good intraocular pressure reducing effect, were more selective, and exhibited a much higher therapeutic index in the eye than PGF2α or its isopropyl ester.The analogues exhibited high activity on FP receptors in a stereoselective manner for the 15a-hydroxyl group.
